$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2017-08-10 AccNo: 0001193125-17-253562 Size: 113 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report: i Filed: 2017-07-31 AccNo: 0001193125-17-242495 Size: 44 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report: n Filed: 2017-07-20 AccNo: 0001193125-17-232117 Size: 15 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report: i Filed: 2017-07-18 AccNo: 0001193125-17-229613 Size: 18 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ CORRESP [Cover] - Correspondence Filed: 2017-06-09 AccNo: 0001193125-17-199565 Size: 7 KB 网页链接
$Recro Pharma, Inc.(REPH)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-06-08 AccNo: 0000000000-17-020075 Size: 133 KB 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2017-07-05 AccNo: 0001193125-17-221508 Size: 16 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$Recro Pharma(REPH)$ 内部交易: 2017-06-14,Possible Member of 10% Group,Flynn James E ,卖出,68000普通股, $6.25
$Recro Pharma(REPH)$ 内部交易: 2017-06-13,Possible Member of 10% Group,Flynn James E ,卖出,32447普通股, $6.59
$Recro Pharma(REPH)$ 内部交易: 2017-06-12,Possible Member of 10% Group,Flynn James E ,卖出,10000普通股, $6.74